Intratumoral sustained release of resiquimod with ablative fractional laser induces efficacy in a cutaneous squamous cell carcinoma mouse model
RSQ-gel with AFL demonstrated significant antitumor efficacy in the cSCC mouse model. Local RSQ-gel combined with adjuvant AFL may offer a promising therapeutic approach for cSCC.
Authors
- Thomas L. Andresen (ORCID: https://orcid.org/0000-0002-1048-127X)
- Fredrik Melander (ORCID: https://orcid.org/0000-0002-3670-6633)
- Uffe H. Olesen (ORCID: https://orcid.org/0000-0002-4578-684X)
- Catharina M. Lerche (ORCID: https://orcid.org/0000-0003-3653-6424)
- Martin Wiinberg (ORCID: https://orcid.org/0000-0001-6999-0557)
- Merete Hædersdal (ORCID: https://orcid.org/0000-0003-1250-2035)
Institutions
- University of Copenhagen (DK)
- Bispebjerg Hospital (DK)
- University College Copenhagen (DK)
- IT University of Copenhagen (DK)
- Technical University of Denmark (DK)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1625867
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00